Fitusiran

4 trials 1 recruiting Orphan designation

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

2 Sponsors

11 Countries

Phase III

Phase II/III

Phase III: 3 Phase II/III: 1

Sponsors using this IMP

Genzyme Corp. 2 Sanofi-Aventis Recherche & Developpement 2

All trials

4 total

A study to investigate the efficacy and safety of fitusiran prophylaxis in male participants aged 1 to less than 12 years with hemophilia A … Recruiting

2025-521858-42-00 Phase III 7 countries Sanofi-Aventis Recherche & Developpement
A study to test a medicine (fitusiran) injected under the skin for preventing bleeding episodes in male adolescent or adult participants wit… Ended

2022-500221-33-01 Phase III 6 countries Sanofi-Aventis Recherche & Developpement
Fitusiran prophylaxis in male pediatric subjects aged 1 to less than 12 years with hemophilia A or B Ended

2024-512501-76-00 Phase II/III 2 countries Genzyme Corp.
Long-term Safety and Efficacy Study of Fitusiran in Patients with Hemophilia A or B, with or without Inhibitory Antibodies to Factor VIII or… Ended

2023-508884-59-00 Phase III 5 countries Genzyme Corp.

Showing 1–4 of 4 trials

← All drugs A–Z